Exact Mass: 610.2539704000001

Exact Mass Matches: 610.2539704000001

Found 18 metabolites which its exact mass value is equals to given mass value 610.2539704000001, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Candesartan cilexetil

1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2-(2H-1,2,3,4-tetrazol-5-yl)-[1,1-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid

C33H34N6O6 (610.2539704000001)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].

   

Gly Trp Trp Tyr

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Gly Trp Tyr Trp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Gly Tyr Trp Trp

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Gly Trp Tyr

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Gly Tyr Trp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]acetamido}-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Trp Gly Tyr

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-(4-hydroxyphenyl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Trp Tyr Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

Trp Tyr Gly Trp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Trp Tyr Trp Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Gly Trp Trp

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Trp Gly Trp

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]acetamido}-3-(1H-indol-3-yl)propanoic acid

C33H34N6O6 (610.2539704000001)


   

Tyr Trp Trp Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]acetic acid

C33H34N6O6 (610.2539704000001)


   

2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil

2-Desethoxy-2-hydroxy-1H-1-Ethyl Candesartan Cilexetil

C33H34N6O6 (610.2539704000001)


   

2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil

2-Desethoxy-2-hydroxy-2H-2-ethyl Candesartan Cilexetil

C33H34N6O6 (610.2539704000001)


   

Candesartan cilexetil

Candesartan cilexetil

C33H34N6O6 (610.2539704000001)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Candesartan Cilexetil (TCV-116) is an angiotensin II receptor inhibitor. Candesartan Cilexetil ameliorates the pulmonary fibrosis and has antiviral and skin wound healing effect. Candesartan Cilexetil can be used for the research of high blood pressure[1][2][3][4][5][6].

   

PA 20:5/7:3;O3

PA 20:5/7:3;O3

C30H43O11P (610.2542857999999)


   

PA 27:8;O3

PA 27:8;O3

C30H43O11P (610.2542857999999)